U.S. flag

An official website of the United States government

NM_213599.3(ANO5):c.2004del (p.Leu669fs) AND multiple conditions

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Jan 23, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003483604.3

Allele description [Variation Report for NM_213599.3(ANO5):c.2004del (p.Leu669fs)]

NM_213599.3(ANO5):c.2004del (p.Leu669fs)

Gene:
ANO5:anoctamin 5 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
11p14.3
Genomic location:
Preferred name:
NM_213599.3(ANO5):c.2004del (p.Leu669fs)
HGVS:
  • NC_000011.10:g.22270417del
  • NG_015844.1:g.82242del
  • NM_001142649.2:c.2001del
  • NM_213599.3:c.2004delMANE SELECT
  • NP_001136121.1:p.Leu668fs
  • NP_998764.1:p.Leu669fs
  • LRG_868t1:c.2004del
  • LRG_868:g.82242del
  • NC_000011.9:g.22291961del
  • NC_000011.9:g.22291963del
  • NM_213599.2:c.2004del
  • NM_213599.2:c.2004delG
  • NM_213599.3:c.2004delGMANE SELECT
Protein change:
L668fs
Links:
dbSNP: rs886043172
NCBI 1000 Genomes Browser:
rs886043172
Molecular consequence:
  • NM_001142649.2:c.2001del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_213599.3:c.2004del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Gnathodiaphyseal dysplasia (GDD)
Synonyms:
GNATHODIAPHYSEAL SCLEROSIS; OSTEOGENESIS IMPERFECTA WITH UNUSUAL SKELETAL LESIONS; Osteogenesis imperfecta Levin type; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008151; MedGen: C1833736; OMIM: 166260
Name:
Autosomal recessive limb-girdle muscular dystrophy type 2L (LGMDR12)
Synonyms:
Limb-girdle muscular dystrophy, type 2L; MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12
Identifiers:
MONDO: MONDO:0012652; MedGen: C1969785; Orphanet: 206549; OMIM: 611307
Name:
Miyoshi muscular dystrophy 3 (MMD3)
Synonyms:
Miyoshi myopathy 3
Identifiers:
MONDO: MONDO:0013222; MedGen: C2750076; Orphanet: 399096; OMIM: 613319

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004228700GenomeConnect - Invitae Patient Insights Network
no classification provided
not providedunknownphenotyping only

SCV005675915Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 23, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknown1not providednot provided1not providedphenotyping only

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GenomeConnect - Invitae Patient Insights Network, SCV004228700.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedphenotyping onlynot provided

Description

Variant interpreted as Pathogenic and reported on 04-06-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknown1not providednot provided1not providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV005675915.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 13, 2025